Furthermore, a HFD can down-regulate CPT2 expression in mice, leading to serum acylcarnitine accumulation, enhancing STAT3 activation, and promoting hepatocellular carcinoma occurrence of in vivo15. The gene discussed is STAT3; the disease is hepatocellular carcinoma.